Home > Cardiology > ISTH 2020 > Pearls of the Posters > Factor V Leiden mutation linked to atrial fibrillation

Factor V Leiden mutation linked to atrial fibrillation

Presented By
Erin Mathiesen Hald, UiT The Arctic University of Norway, Tromsø, Norway
ISTH 2020
Cohort study, Tromsø Study
A novel cohort analysis from the Tromsø Study found that specifically men with factor V Leiden (FVL) mutation have an elevated risk for atrial fibrillation. However, FVL mutation was not identified as a general risk factor for ischaemic stroke [1]. Atrial fibrillation is an established prothrombotic disease that may lead to ischaemic stroke. The FVL mutation is known to be a risk for venous thromboembolism and is also connected with arterial disease and unfavourable outcomes of pregnancies in carriers. The aim of this sub-analysis, presented by PhD student Erin Mathiesen Hald (UiT The Arctic University of Norway, Norway), was to evaluate a possible association of FVL with atrial fibrillation and successive ischaemic stroke. This analysis included data form a randomly selected sub-cohort of 3,663 subjects from the fourth survey of general population within the Tromsø Study (1994/1995). Blood samples from all participants we...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on